MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

No Stability Information

Alfuzosin 2.5mg tablets (Medihealth (Northern) Ltd)

Explore other Alfuzosin formulations Explore other Alfuzosin 2.5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Alfuzosin 2.5mg tablets (Milpharm Ltd)

Explore other Alfuzosin formulations Explore other Alfuzosin 2.5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Alfuzosin 2.5mg tablets (Phoenix Healthcare Distribution Ltd)

Explore other Alfuzosin formulations Explore other Alfuzosin 2.5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Alfuzosin 2.5mg tablets (Sigma Pharmaceuticals Plc)

Explore other Alfuzosin formulations Explore other Alfuzosin 2.5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Alfuzosin 2.5mg tablets (Teva UK Ltd)

Explore other Alfuzosin formulations Explore other Alfuzosin 2.5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Alfuzosin 2.5mg tablets (Zentiva Pharma UK Ltd)

Explore other Alfuzosin formulations Explore other Alfuzosin 2.5mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Use with caution

Alimemazine 10mg tablets (A A H Pharmaceuticals Ltd)

Explore other Alimemazine formulations Explore other Alimemazine 10mg tablets suppliers

Stability Notes

Alimemazine powder may darken on exposure to light.

Provenance

This compatibility recommendation is derived from Alimemazine 10mg tablets (Zentiva Pharma UK Ltd).

Use with caution

Alimemazine 10mg tablets (Alliance Healthcare (Distribution) Ltd)

Explore other Alimemazine formulations Explore other Alimemazine 10mg tablets suppliers

Stability Notes

Alimemazine powder may darken on exposure to light.

Provenance

This compatibility recommendation is derived from Alimemazine 10mg tablets (Zentiva Pharma UK Ltd).

Use with caution

Alimemazine 10mg tablets (Key Pharmaceuticals Ltd)

Explore other Alimemazine formulations Explore other Alimemazine 10mg tablets suppliers

Stability Notes

Alimemazine powder may darken on exposure to light.

Provenance

This compatibility recommendation is derived from Alimemazine 10mg tablets (Zentiva Pharma UK Ltd).

Use with caution

Alimemazine 10mg tablets (Medihealth (Northern) Ltd)

Explore other Alimemazine formulations Explore other Alimemazine 10mg tablets suppliers

Stability Notes

Alimemazine powder may darken on exposure to light.

Provenance

This compatibility recommendation is derived from Alimemazine 10mg tablets (Zentiva Pharma UK Ltd).

Use with caution

Alimemazine 10mg tablets (Phoenix Healthcare Distribution Ltd)

Explore other Alimemazine formulations Explore other Alimemazine 10mg tablets suppliers

Stability Notes

Alimemazine powder may darken on exposure to light.

Provenance

This compatibility recommendation is derived from Alimemazine 10mg tablets (Zentiva Pharma UK Ltd).

Use with caution

Alimemazine 10mg tablets (Zentiva Pharma UK Ltd)

Explore other Alimemazine formulations Explore other Alimemazine 10mg tablets suppliers

Stability Notes

Alimemazine powder may darken on exposure to light.

Provenance

This compatibility recommendation is derived from Alimemazine 10mg tablets (Zentiva Pharma UK Ltd).

No Stability Information

Alitretinoin 10mg capsules (A A H Pharmaceuticals Ltd)

Explore other Alitretinoin formulations Explore other Alitretinoin 10mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Alitretinoin 10mg capsules (Alliance Healthcare (Distribution) Ltd)

Explore other Alitretinoin formulations Explore other Alitretinoin 10mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Alitretinoin 10mg capsules (Ennogen Healthcare International Ltd)

Explore other Alitretinoin formulations Explore other Alitretinoin 10mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.
Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.